Inhibition of tumor progression using antisense oligonucleotide targeting Gli2 in androgen independent prostate cancer

被引：0
|
作者：
Narita, Shintaro
So, Alan I.
Sinnemann, Shannon
Fazli, Ladan
Marcusson, Eric G.
Gleave, Martin E.
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)30415-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [41] Progression of androgen independent prostate cancer more than just HOTAIR
    Clarkson, Michael
    Tolich, Nadia
    Costello, Anthony
    Corcoran, Niall M.
    Hovens, Christopher M.
    BJU INTERNATIONAL, 2016, 118 : 27 - 27
  • [42] Targeting androgen-independent prostate cancer through epigenetic reprogramming
    Puca, Loredana
    Gao, Dong
    Kossai, Myriam
    Cyrta, Joanna
    Marotz, Clarisse
    Mosquera, Juan Miguel
    MacDonald, Theresa Y.
    Sboner, Andrea
    Rao, Rema
    Chen, Yu
    Rubin, Mark A.
    Beltran, Himisha
    CANCER RESEARCH, 2016, 76
  • [43] Targeting androgen independent prostate cancer via nutritional and oxidative stress
    Wu, Chunjing
    Wangpaichitr, Medhi
    Perez-Stable, Carlos
    Feun, Lynn
    Savaraj, Niramol
    CANCER RESEARCH, 2009, 69
  • [44] Tea components delayed progression of androgen-independent prostate tumor in an orthotopic prostate tumor model.
    Zhou, JR
    Yu, LY
    Blackburn, GL
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1170S - 1170S
  • [45] Heterogeneous androgen receptor (AR) protein expression in metastatic androgen-independent prostate cancer: implications for complex AR mechanisms in the progression to androgen independent prostate cancer
    Shah, RB
    Chinnaiyan, A
    Mehra, R
    Varambally, S
    Shen, R
    Harwood, J
    Bismar, R
    Kim, R
    Pienta, K
    Rubin, MA
    MODERN PATHOLOGY, 2005, 18 : 163A - 163A
  • [46] Heterogeneous androgen receptor (AR) protein expression in metastatic androgen-independent prostate cancer: Implications for complex AR mechanisms in the progression to androgen independent prostate cancer
    Shah, RB
    Chinnaiyan, A
    Mehra, R
    Varambelly, S
    Shen, R
    Harwood, J
    Bismar, T
    Kim, R
    Pienta, K
    Rubin, MA
    LABORATORY INVESTIGATION, 2005, 85 : 163A - 163A
  • [47] SPOP modulates GLI3-dependent SHH signaling in androgen independent prostate cancer
    Oldenbroek, M.
    Boyer, T. G.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [48] Genetic alterations occurring after treatment of prostate cancer cells with an antisense androgen receptor oligonucleotide or bicalutamide
    Eder, IE
    Haag, P
    Mousses, S
    Basik, M
    Bartsch, G
    Klocker, H
    JOURNAL OF UROLOGY, 2003, 169 (04): : 57 - 57
  • [49] Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis
    Kramann, Rafael
    Fleig, Susanne V.
    Schneider, Rebekka K.
    Fabian, Steven L.
    Di Rocco, Derek P.
    Maarouf, Omar
    Wongboonsin, Janewit
    Ikeda, Yoichiro
    Heckl, Dirk
    Chang, Steven L.
    Rennke, Helmut G.
    Waikar, Sushrut S.
    Humphreys, Benjamin D.
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (08): : 2935 - 2951
  • [50] Inhibition of LDHA suppresses tumor progression in prostate cancer
    Xian, Zhi-Yong
    Liu, Jiu-Min
    Chen, Qing-Ke
    Chen, Han-Zhong
    Ye, Chu-Jin
    Xue, Jian
    Yang, Huan-Qing
    Li, Jing-Lei
    Liu, Xue-Feng
    Kuang, Su-Juan
    TUMOR BIOLOGY, 2015, 36 (10) : 8093 - 8100
12345